Analyst Moves: REGN, AGN, STX - Presented by: The Aol. On Network

This morning, JMP upgraded shares of Regeneron (REGN) from market perform to outperform as the company's newest cholesterol drug will boost future earnings. With the upgrade, JMP set a $290 price target.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 17.98 0.05 ▲ 0.28%
GILD $ 91.29 1.84 ▲ 2.06%
RAD $ 7.26 0.09 ▼ 1.22%
ARCP $ 8.33 unch
S $ 4.19 0.05 ▼ 1.18%
GE $ 25.83 0.05 ▼ 0.19%
PBR $ 7.60 0.11 ▼ 1.43%
AAPL $ 112.01 0.53 ▼ 0.47%

As of 12/24/2014, 02:12 PM
More Most Active